Atul Pande - Nov 1, 2021 Form 4 Insider Report for Karuna Therapeutics, Inc. (KRTX)

Role
Director
Signature
/s/ Troy Ignelzi, Attorney-in-Fact
Stock symbol
KRTX
Transactions as of
Nov 1, 2021
Transactions value $
-$301,675
Form type
4
Date filed
11/3/2021, 04:14 PM
Previous filing
Oct 1, 2021
Next filing
Dec 2, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRTX Common Stock Options Exercise $40K +2.5K $16.00* 2.5K Nov 1, 2021 Direct
transaction KRTX Common Stock Sale -$342K -2.5K -100% $136.67 0 Nov 1, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRTX Option (right to buy) Options Exercise $0 -2.5K -25% $0.00 7.5K Nov 1, 2021 Common Stock 2.5K $16.00 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 1, 2021.